short history of anti-rheumatic therapy. IV. Corticosteroids

Abstract

In 1948 a corticosteroid compound was administered for the first time to a patient affected by rheumatoid arthritis by Philip Showalter Hench, a rheumatologist at the Mayo Clinic in Rochester, Minnesota (USA). He was investigating since 1929 the role of adrenal gland-derived substances in rheumatoid arthritis. For the discovery of cortisone and its applications in anti-rheumatic therapy, Hench, along with Edward Calvin Kendall and Tadeusz Reichstein, won the 1950 Nobel Prize for Medicine. In this review we summarize the main stages that led to the identification of the so-called compound E, which was used by Hench. We also consider the subsequent development of steroid therapy in rheumatic diseases, through the introduction of new molecules with less mineralocorticoid effects, such as prednisone, and more recently, deflazacort.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Info
Issue
Section
Survey/Comments
Statistics
  • Abstract views: 1082

  • PDF: 1335
How to Cite
Pasero, G., & Marson, P. (1). short history of anti-rheumatic therapy. IV. Corticosteroids. Reumatismo, 62(4), 292-299. https://doi.org/10.4081/reumatismo.2010.292